Last reviewed · How we verify

NCT04595201

Clinical Follow-up of Pregnant Subjects Undergoing NIPT

Recruiting now Last updated 16 October 2024
What this trial tests

trial testing NIPT in Pregnancy in 25,000 participants. Currently enrolling.

Timeline
13 October 2020
Primary endpoint
13 October 2025
13 October 2025

Quick facts

Lead sponsorSequenom, Inc.
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment25,000
Start date13 October 2020
Primary completion13 October 2025
Estimated completion13 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sequenom, Inc.

Who can join

18 and older, female only, with Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To obtain pregnancy outcome data from patients screened for fetal genetic status using non-invasive pregnancy testing (NIPT).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of NIPT

Trials testing the same drug.

Other recruiting trials for Pregnancy

Currently open trials in the same condition.

Other Sequenom, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04595201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing